Performance analysis of Actuate Therapeutics (ACTU)
Annual Return
Since Aug 13, 2024, ACTU has had an average annual return of -57.71%, underperforming the benchmark SPY, which returned +21.46% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -70.26% | -23.12% | -7.55% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.04% | -20.59% | -26.75% | +7.32% | -31.30% | -9.89% | -70.26% | ||||||
| 2025 | +13.45% | -19.82% | -6.49% | +35.89% | +29.35% | -48.66% | +18.66% | +16.43% | -20.74% | -0.45% | +14.57% | -19.79% | -23.12% |
| 2024 | -6.50% | -7.45% | +9.13% | +0% | -2.10% | -7.55% |
Drawdown analysis of Actuate Therapeutics (ACTU)
The maximum drawdown for the ACTU was -85.54%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The current ACTU drawdown is -84.70%.
Since Aug 13, 2024 ACTU has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -85.54% | May 30, 2025 | 216 | Apr 10, 2026 | Ongoing | Ongoing | Ongoing |
| -40.82% | Jan 23, 2025 | 26 | Mar 3, 2025 | 62 | May 30, 2025 | 88 |
| -36.61% | Aug 14, 2024 | 29 | Sep 25, 2024 | 23 | Oct 28, 2024 | 52 |
| -26.65% | Oct 28, 2024 | 38 | Dec 20, 2024 | 18 | Jan 21, 2025 | 56 |